Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
Pharmacogenomics · 2024
DOI: 10.2217/pgs-2024-0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics, 2024. Verfasst von Guilherme Suarez-Kurtz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Pharmacogenetics, South American People, Tacrolimus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
This study shows that the distribution of CYP3A5 alleles (*1, *3, *6 and *7) and genotype-predicted CYP3A5 phenotypes vary significantly across Latin American cohorts (Brazilians and the One Thousand Genomes Admixed American superpopulation), as well as among subcohorts comprising individuals with the highest proportions of Native, European or sub-Saharan African ancestry. Differences in biogeographical ancestry across the study groups are the likely explanation for these results. The differential distribution of CYP3A5 phenotypes has major pharmacogenomic implications, affecting the proportion of individuals carrying high risk CYP3A5 phenotypes for the immunosuppressant tacrolimus and the number of patients that would need to be genotyped to prevent acute rejection in kidney transplant recipients under tacrolimus treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
- Escola de Matemática Aplicada, Fundação Getúlio Vargas, Rio de Janeiro, RJ, Brazil.
ORCID-Profile: Guilherme Suarez-Kurtz, Claudio José Struchiner
Zitieren
APA
Suarez-Kurtz, G., & Struchiner, C. J. (2024). Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics. https://doi.org/10.2217/pgs-2024-0009
Vancouver
Suarez-Kurtz G, Struchiner CJ. Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics. 2024. doi:10.2217/pgs-2024-0009
BibTeX
@article{SuarezKurtz2024,
author = {Suarez-Kurtz, Guilherme and Struchiner, Claudio José},
title = {Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations},
journal = {Pharmacogenomics},
year = {2024},
doi = {10.2217/pgs-2024-0009}
}
EUVIMED